Prospective cohort study demonstrates admission CRP-to-albumin ratio predicts three-month post-discharge mortality in sepsis, highlighting its value as an accessible prognostic biomarker.
Background Sepsis is characterized by a dysregulated host inflammatory response to infection, leading to organ dysfunction and high mortality. Because systemic inflammation increases C-reactive protein (CRP) and suppresses albumin synthesis, the CRP/albumin (CRP/Alb) ratio has emerged as a potential prognostic marker. However, evidence from emergency settings, particularly in low- and middle-income countries such as Iran, remains limited. This study evaluated the prognostic value of the admission CRP/Alb ratio for in-hospital mortality, 1-month post-discharge mortality, and mortality between 1 and 3 months after discharge in patients with sepsis. Methods In this prospective study, 200 septic patients who presented to the Emergency Department (ED) of Al-Zahra Hospital in Isfahan, Iran, during a course of one year were enrolled. CRP and albumin levels were measured at ED admission to calculate the admission CRP/Alb ratio. Vital status was assessed during hospitalization and at 1 and 3 months after hospital discharge. Univariable and multivariable logistic regression analyses were used to assess the association between the admission CRP/Alb ratio and mortality. Receiver operating characteristic (ROC) analysis was performed to evaluate its discriminatory ability and determine the optimal cut-off value. Results In-hospital mortality was 67.0% (134/200). Among patients discharged alive, 1-month post-discharge mortality was 13.6% (9/66). Among patients alive at the 1-month post-discharge follow-up, mortality between 1 and 3 months after discharge was 21.1% (12/57). The admission CRP/Alb ratio was significantly higher in patients who died between 1 and 3 months after discharge than in survivors ( p = 0.016). The CRP/Alb ratio remained associated with later post-discharge mortality after adjustment for potential confounders (adjusted OR = 1.05; 95% CI: 1.01–1.10; p = 0.014). ROC analysis showed moderate prognostic value, with an area under the curve of 0.72 (95% CI: 0.551–0.899; p = 0.017). The optimal cut-off value was 24.68, yielding 83% sensitivity and 60% specificity. Conclusions The admission CRP/Alb ratio measured at ED presentation may serve as a simple, accessible, and potentially useful biochemical marker for identifying septic patients at increased risk of later post-discharge mortality. However, given the limited number of post-discharge events, these findings should be interpreted cautiously and validated in larger multicenter cohorts.
No takes yet. Share an insight, caveat, or question.
Hashemi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: